Skip to main content
    N

    National Health Investors Inc (NHI)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $60.68
    -2.27 (-3.61%)

    Market Cap: $3.09B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    National Health Investors Inc (NHI) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    FFO per share for National Health Investors (NHI) was $4.74 for 2025. In the quarter ended Sep 30, 2026, National Health Investors reported EPS of $1.12, below the $1.17 estimate. It beat the EPS estimate in 4 of the last 8 quarters. National Health Investors is expected to report earnings on Feb 24, 2027.

    Earnings

    Performance (10Y)

    Beat Rate
    43%(17/40)
    Avg Surprise
    -4.75%

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.72
    Range$0.66 - $0.79
    6 analysts
    Revenue Consensus
    $114.78M
    Range$107.21M - $126.89M
    7 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.73
    Range$0.73 - $0.73
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.75-2.7%
    60d ago$0.75-2.7%
    30d ago$0.75-2.7%
    7d ago$0.75-2.7%
    Current$0.73
    Revenue Consensus
    $116.15M
    Range$109.64M - $123.96M
    5 analysts

    Next Report

    NHI has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 41.0% below the $1.22 reported for the quarter ended Dec 31, 2025.

    NHI Earnings Call

    The latest NHI earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, NHI beat 17, missed 21 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $113.48M, up 26.3% from $89.85M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.12$1.17$0.68 - $1.93-4.27%Miss+62.3%30 up, 1 downNov 9, 2026$113.48M
    Jun 30, 2026$1.19$1.26N/A-5.56%Miss+50.6%11 up, 0 downAug 10, 2026$121.32M
    Mar 31, 2026$0.77$0.86$0.79 - $0.92-10.47%Miss+2.7%30 up, 0 downMay 4, 2026$115.13M
    Dec 31, 2025$1.22$1.23N/A-0.81%Miss+50.0%30 up, 0 downFeb 26, 2026$105.71M
    Sep 30, 2025$0.69$0.60$0.55 - $0.65+15.00%Beat+6.2%20 up, 0 downNov 6, 2025$89.85M
    Jun 30, 2025$0.79$0.75$0.74 - $0.76+5.33%Beat-1.3%20 up, 0 downAug 6, 2025$90.66M
    Mar 31, 2025$0.75$0.71$0.71 - $0.71+5.63%Beat+5.6%10 up, 0 downMay 5, 2025$89.30M
    Dec 31, 2024$0.81$0.75$0.72 - $0.80+8.24%Beat+9.9%30 up, 0 downFeb 25, 2025$84.24M
    Sep 30, 2024$0.65$0.70$0.67 - $0.79-7.14%Miss-4.4%51 up, 0 downNov 5, 2024$82.94M
    Jun 30, 2024$0.80$0.71N/A+12.68%Beat-13.0%20 up, 0 downAug 6, 2024$86.49M
    Mar 31, 2024$0.71$0.69$0.67 - $0.69+2.90%Beat-10.1%50 up, 0 downMay 6, 2024$81.51M
    Dec 31, 2023$0.74$0.68$0.67 - $0.70+8.82%Beat+1380.0%40 up, 0 downFeb 20, 2024$79.47M
    Sep 30, 2023$0.68$0.72$0.67 - $0.77-5.56%Miss-12.8%50 up, 0 downNov 7, 2023$80.11M
    Jun 30, 2023$0.92$0.69$0.69 - $0.69+33.33%Beat+95.7%10 up, 0 downAug 8, 2023$77.88M
    Mar 31, 2023$0.79$0.65N/A+21.54%Beat+19.7%21 up, 0 downMay 9, 2023$82.39M
    Dec 31, 2022$0.05$0.69N/A-92.75%Miss-64.3%10 up, 0 downFeb 21, 2023$99.01M
    Sep 30, 2022$0.78$0.72N/A+8.33%Beat+8.3%10 up, 0 downNov 8, 2022$76.30M
    Jun 30, 2022$0.47$0.80N/A-41.25%Miss-33.8%10 up, 0 downAug 8, 2022$59.90M
    Mar 31, 2022$0.66$0.74N/A-10.81%Miss-16.5%10 up, 0 downMay 9, 2022$71.33M
    Dec 31, 2021$0.14$0.93$0.86 - $0.99-84.95%Miss-83.1%20 up, 0 downFeb 22, 2022$69.67M
    Sep 30, 2021$0.72$0.75N/A-4.00%Miss-25.8%10 up, 0 downNov 8, 2021$73.83M
    Jun 30, 2021$0.71$0.90$0.88 - $0.92-21.11%Miss-29.7%3N/AAug 9, 2021$74.33M
    Mar 31, 2021$0.79$0.86$0.81 - $0.95-8.14%Miss-13.2%3N/AMay 10, 2021$80.89M
    Dec 31, 2020$0.83$1.01$0.98 - $1.05-17.82%Miss-12.6%3N/AFeb 22, 2021$81.26M
    Sep 30, 2020$0.97$0.97$0.80 - $0.990.00%In line0.0%4N/ANov 9, 2020$84.30M
    Jun 30, 2020$1.01$1.04$0.96 - $1.04-2.88%Miss+9.8%4N/AAug 10, 2020$84.17M
    Mar 31, 2020$0.91$0.96N/A-5.21%Miss+9.6%2N/AMay 11, 2020$83.08M
    Dec 31, 2019$0.95$0.95$0.94 - $0.950.00%In line+9.2%2N/AFeb 19, 2020$82.20M
    Sep 30, 2019$0.97$0.95$0.94 - $0.96+2.11%Beat0.0%4N/ANov 7, 2019$81.68M
    Jun 30, 2019$0.92$0.93$0.91 - $1.00-1.08%Miss+1.1%4N/AAug 8, 2019$78.10M
    Mar 31, 2019$0.83$0.88$0.86 - $1.06-5.68%Miss-11.7%3N/AMay 7, 2019$76.11M
    Dec 31, 2018$0.87$0.96$0.95 - $0.96-9.38%Miss-7.4%3N/AFeb 19, 2019$74.00M
    Sep 30, 2018$0.97$0.96$0.95 - $0.96+1.04%Beat+3.2%4N/ANov 6, 2018$74.92M
    Jun 30, 2018$0.91$0.96$0.95 - $0.96-5.21%Miss-2.2%3N/AAug 7, 2018$72.96M
    Mar 31, 2018$0.94$0.92$0.91 - $0.96+2.17%Beat+10.6%5N/AMay 8, 2018$72.75M
    Dec 31, 2017$0.94$0.92$0.84 - $0.95+2.17%Beat-8.7%6N/AFeb 16, 2018$71.10M
    Sep 30, 2017$0.94$0.91$0.85 - $0.93+3.30%Beat+9.3%6N/ANov 8, 2017$71.35M
    Jun 30, 2017$0.93$0.88$0.86 - $0.88+5.68%Beat+9.4%4N/AAug 9, 2017$69.83M
    Mar 31, 2017$0.85$0.86N/A-1.16%Miss+4.9%N/AN/AMay 9, 2017$66.38M
    Dec 31, 2016$1.03$0.88N/A+17.05%Beat-28.5%N/AN/AFeb 17, 2017$64.99M
    Last 40 quarters

    Annual FFO

    FFO per share was $4.74 for 2025, down 3.5% from $4.91 in 2024. It was $4.67 for 2016, the oldest of the 10 years shown.

    Fiscal yearFFO per shareChange
    2025$4.74-3.5%
    2024$4.91+14.2%
    2023$4.30-6.5%
    2022$4.60-17.9%
    2021$5.60+1.8%
    2020$5.50+0.4%
    2019$5.48+2.8%
    2018$5.33+9.4%
    2017$4.87+4.3%
    2016$4.67N/A

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $3.45, up 16.0% from the year before. It was $3.55 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$3.45+16.0%
    Dec 31, 2024$2.97-5.0%
    Dec 31, 2023$3.13+59.7%
    Dec 31, 2022$1.96-16.9%
    Dec 31, 2021$2.36-36.6%
    Dec 31, 2020$3.72+1.4%
    Dec 31, 2019$3.67N/A
    Dec 31, 2018$3.69N/A
    Dec 31, 2017$3.66+3.1%
    Dec 31, 2016$3.55N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,100 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,11711
    2026Q2Jun 30, 20266,36611
    2026Q1Mar 31, 20265,69410
    2025Q4Dec 31, 20256,89311
    2025Q3Sep 30, 20255,63010
    2025Q2Jun 30, 20255,3159
    2025Q1Mar 31, 20256,89510
    2024Q4Dec 31, 20245,81811

    2026Q3 Earnings Call

    Opening remarks

    Dana Hambly Senior Vice President of Finance Thank you, and welcome to the National Health Investors Third Quarter 2026 Conference Call. On the call today are Eric Mendelsohn, President and CEO; Kevin Pascoe, Chief Investment Officer; Todd Siefert, Chief Financial Officer; Chris Maingot, Chief Operating Officer; and David Travis, Chief Accounting Officer. Yesterday, NHI released its third quarter results and conference call information for a press release after market close. Today's remarks may include forward-looking statements, which are subject to risks or uncertainties and are not guarantees of future performance. Investors are urged to carefully review NHI's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2025, and Form 10-Q for the quarter ended September 30, 2026, for a discussion of these risks. Copies of these filings are available on the SEC's website at sec.gov or on NHI's website at nhireit.com. In addition, today's call may include certain non-GAAP financial measures, reconciliations of which are provided in NHI's earnings release, which has been furnished to the SEC on Form 8-K. Listeners are encouraged to review those reconciliations provided in the earnings release together with all other information provided in that release. I'll now turn the call over to our CEO, Eric Mendelsohn.

    Eric Mendelsohn President and CEO Good morning, and thank you for joining us. This has been a year of significant transition for NHI. We completed the sale of the NHC portfolio on July 1, substantially reduced our skilled nursing exposure, and accelerated our investment in private pay senior housing. Our conviction in SHOP remains strong. We continue to see the most attractive risk-adjusted opportunities for our capital in private pay senior housing, where we believe that the industry backdrop provides powerful and sustained tailwinds for our company. Capturing that opportunity requires both disciplined underwriting and consistent execution. While NHI is focused on the long-term opportunity, we understand the importance of delivering consistent quarterly results. In that regard, our third quarter SHOP performance fell short of our expectations. Our 15 same-store properties delivered approximately 19.5% year-over-year NOI growth, consistent with our outlook, but recent performance in the non-same-store communities reduced the contribution we expected from the total portfolio in the quarter. We're not satisfied with those results and are addressing the operating performance with our partners. Our longer-term growth outlook for those properties is unchanged. Chris Maingot, our new COO, will discuss the drivers and our response in more detail. The NHC sale provided $555 million in net proceeds to support NHI's repositioning. We expect to recycle more than 95% of those proceeds before year-end, primarily into SHOP and expected SHOP transition investments. We've already completed more than $395 million in investments year-to-date and expect significant additional closings during the fourth quarter.

    Frequently Asked Questions About NHI

    When is National Health Investors's next earnings date?

    National Health Investors's next earnings report is expected for Feb 24, 2027.

    Did NHI beat earnings estimates last quarter?

    No. National Health Investors reported EPS of $1.12 for the quarter ended Sep 30, 2026, below the $1.17 estimate by 4.27%.

    What EPS do analysts expect from NHI next quarter?

    The consensus EPS estimate for National Health Investors for the quarter ending Dec 31, 2026 is $0.72 from 6 analysts, with estimates from $0.66 to $0.79.

    How often does NHI beat earnings estimates?

    National Health Investors beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +1.64%.